Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V LeFever

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and biological evaluation of novel potent antagonists of the bombesin/gastrin releasing peptide receptorM Mokotoff, K Ren, L K Wong, et al.
Transplantation|April 1, 1984
Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic miceA V LeFever, R L Truitt, C C Shih, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 7, 2001
Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trialL G Lum, A V LeFever, J S Treisman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1983
Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivoR L Truitt, C Y Shih, A V Lefever, et al.
Surgery|February 1, 1976
Immunotherapy with neuraminidase-treated cells and bacillus Calmette-GuerinG M Kollmorgen, J J Killion, W A Sansing, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancerN K Garlie, A V LeFever, R E Siebenlist, et al.
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumorsM Sen, D M Wankowski, N K Garlie, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Medicinal Chemistry|December 11, 1992
Synthesis and biological evaluation of novel potent antagonists of the bombesin/gastrin releasing peptide receptorM Mokotoff, K Ren, L K Wong, et al.
Transplantation|April 1, 1984
Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic miceA V LeFever, R L Truitt, C C Shih, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 7, 2001
Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trialL G Lum, A V LeFever, J S Treisman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1983
Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivoR L Truitt, C Y Shih, A V Lefever, et al.
Surgery|February 1, 1976
Immunotherapy with neuraminidase-treated cells and bacillus Calmette-GuerinG M Kollmorgen, J J Killion, W A Sansing, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancerN K Garlie, A V LeFever, R E Siebenlist, et al.
Journal of Hematotherapy & Stem Cell Research|May 22, 2001
Use of anti-CD3 x anti-HER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu+ tumorsM Sen, D M Wankowski, N K Garlie, et al.
Pageof 2